Table 3 Stability Verification of EPO N-Glycans
From: High-throughput glycosylation screening method for biologics development using MALDI-TOF-MS
No | Composition | Sample MW(M+Na) | CV |
|---|---|---|---|
A1 | H6N2P1 | 1521.424 | 5.43% |
A2 | H5N4F1S2 | 2355.809 | 2.05% |
A3 | H6N5F1S2 | 2720.941 | 9.03% |
A4 | H6N5F1S3 | 2994.026 | 8.51% |
A5 | H7N6F1S2 | 3086.073 | 7.86% |
A6 | H7N6F1S3 | 3359.158 | 12.13% |
A7 | H7N6F1S4 | 3632.243 | 12.75% |
A8 | H8N7F1S3 | 3724.29 | 9.86% |
